Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share
-
Shares outstanding
-
9,036,176
-
Total 13F shares
-
24,767,928
-
Share change
-
-4,718,852
-
Total reported value
-
$71,168,352
-
Price per share
-
$2.91
-
Number of holders
-
48
-
Value change
-
-$30,970,776
-
Number of buys
-
31
-
Number of sells
-
21
Institutional Holders of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) as of Q2 2022
As of 30 Jun 2022 Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) had 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 24,767,928 shares of stock of the company.
Largest 10 holders included MASSACHUSETTS FINANCIAL SERVICES CO /MA/, Kynam Capital Management, LP, ARK Investment Management LLC, VANGUARD GROUP INC, BlackRock Inc., ORBIMED ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, CREDIT SUISSE AG/, and BARCLAYS PLC.
This table shows 48 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.